Consistent with CRC patients presenting with a general immunocompromised state, CRC patients and healthy donors displayed similar proportions of circulating T-cells (both CD4+ and CD8+), NK cells and NKT cells [92] but circulating T-regs were increased in CRC patients [79]. This evidence concerns the gene CD4 and colorectal carcinoma.